Mr. Rulli (for himself and Mrs. Harshbarger) introduced the following bill
Support legislation to prohibit treating a biologic as a biological product solely because it contains a protein that is a clinically inactive component.
Occurrences
Evidence
Action: Mr. Rulli (for himself and Mrs. Harshbarger) introduced the following bill; which was referred to the Committee on Energy and Commerce. Full title: To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
The Congressional Record for April 30, 2026 includes the introduction of H.R. 8630 by Mr. Rulli.
Assessments
Rulli materially supported the promise by introducing H.R. 8630, a bill whose text closely matches the pledged policy to bar treating a biologic as a biological product solely because it contains a clinically inactive protein component. However, the available evidence shows only introduction and referral to committee, with no passage, enactment, or later successful incorporation into law. That means he took concrete action but did not yet deliver the promised policy outcome.